Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate for Pseudovitelliform Detachment
NCT00211432Phase 2Completed
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- Apr 2008
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in Acquired vitelliform lesion (AVL), sponsored by Manhattan Eye, Ear and Throat Hospital. Started Apr 2008; status: completed.
02
Drugs
anecortave
03
Conditions
Acquired vitelliform lesion (AVL)
Beyond the preview
Go deeper on NCT00211432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211432.